Video Shorts

Looking to the Future of TNBC Treatment Development and Sequencing

Implications of the FDA Approval of Daratumumab Plus VRd in Transplant-Ineligible Myeloma

Highlighting the Future of the HNSCC Treatment Paradigm

Reviewing ASCO GU 2026 and its Most Important Coverage

Why Is CRC Incidence Rising Among Younger, Fit Patients? Drs Marshall and Lieu Weigh In

Breaking Down the Top 2 Bladder Cancer Abstracts From ASCO GU: With Chandler Park, MD, FACP

Exploring the Mechanism of Action of FX909

Characterization of Responders to EV Plus Pembrolizumab in mUC

Targeted Therapy and Surgical Advances Move the Needle in Chondrosarcoma

Top 3 Trials in RCC You Won’t Want to Miss At ASCO GU 2026: With Chandler Park, MD, FACP

ASCO GU Attendees Preview the Top Abstracts, Personal Conference Must-Haves

Exploring Ipilimumab/Nivolumab Outcomes by Age in ccRCC

Exploring Frontline Outcomes With Ipilimumab/Nivolumab by Number of Doses in RCC

Phase 2 Trial Shows Efficacy of Pumitamig in Metastatic TNBC

Exploring ctDNA Dynamics in the IMvigor011 Trial

Unpacking the Final Data From SunRISe-2

Top ASCO GU 2026 Abstracts According to Fellows

Imaging Modalities for Metastatic Breast Cancer Diagnosis and Staging

Rising Stars in GU Oncology Share New Data at OncLive Fellows Forum

Examining Alternative Splicing in Metastatic Bladder Cancer

Sarcomatoid vs Rhabdoid Dedifferentiation Outcomes in mccRCC

The Exploration of Golcadomide in LBCL Management

Important Upcoming Clinical Trials to Watch For in MCL

Subcutaneous Blinatumomab Demonstrates Promising Efficacy and Safety in First Patient With MPAL

Real-World Data for Luspatercept in Lower-Risk MDS

Implications of the Negative VERONA Trial of Venetoclax/Azacitidine in Higher-Risk MDS

First TTFields Approval in Pancreatic Cancer Paves Way for More Multimodal Approaches

Understanding the Therapeutic Team Delivery Concept in Oncology

Reexamining the Definition of Postpartum Breast Cancer

OncLive News Roundup for the Week of 2/15